Matthew J. Rhenish serves as senior vice president of Pharmacy & Business Growth Strategy for Highmark's Diversified Business & Growth Organization. In this role, he drives growth strategies and strategic endeavors across the enterprise. He is responsible for Highmark's Pharmacy Business which serves both Highmark Health Plans and other health plans. Matt also is responsible for Helion, a company that manages high-performance post-acute care networks through value-based reimbursement designs and technology solutions that enable providers to achieve better outcomes and lower cost for members across various sites of care (SNF, IRF, LTAC, home).
Prior to this role, he served as senior vice president of Pharmacy & Market Growth Strategies for Highmark Inc. where he had direct responsibility for pharmacy, sales operations, product development, portfolio management, sales training, and health plan growth strategies.
Mr. Rhenish previously held the position of president of national and specialty markets, president and chief operating officer of HM Insurance Group and pharmacy markets in addition to multiple positions at the consulting firm McKinsey & Company. During his time at McKinsey, he worked closely with payors to identify strategies related to health care reform. He also previously served as manager of corporate strategy at Cardinal Health, a multinational health care industry services provider.
Mr. Rhenish received his MBA from Harvard Business School and earned a BSBA in finance with honors and with distinction from The Ohio State University.
Current Board of Director affiliations include:
Thought Leadership Topics:
Controlling drug costs in healthcare
Managing health care costs through product designs
Value of ancillary product lines
Health plan strategies